The U.S. Veterans Administration oversees the medical care of the United States Armed Forces veterans. It has complete medical records of every veteran, including their hospitalizations, vaccinations, deaths, and more.
Therefore, studies of veterans that include sub-populations broken down by vaccination status provide accurate data about the effectiveness of COVID vaccines. I already reported on two such studies: one shows that COVID and flu vaccines are useless at preventing hospitalization due to COVID or flu, and another (posted on Feb 2022) proves that Covid vaccines cause myocarditis in veterans.
A new study was published in the Journal of Infectious Diseases and is worth a look.
The study is very straightforward: it looked at 1,459 veterans receiving Merck’s Molnupiravir and compared them with 63,281 veterans NOT receiving it. Its objective was to see if Molnupiravir was helpful (drumroll, it was not). The period covered was from Jan 1 to August 21, 2022.
The study has the breakdown of the Molnupiravir group and the standard-treatment group by vaccination status.
Such a breakdown allows us to check which veterans did better: the COVID-vaccinated or the unvaccinated….